EASL 2014

Welcome to the Highlights from EASL 2014 resource page. This is your central portal for information presented at The International Liver Congress in London. In addition to breaking news, this page features onsite video interviews with leading experts to get their reactions to some of the clinical updates and news presented at the conference, and what implications they have on patient care and practice.


Video Coverage: EASL 2014



NASH with liver transplantation related to early CVD mortality

LONDON — Patients who underwent perioperative liver transplantation and had nonalcoholic steatohepatitis were at increased risk for early cardiovascular disease-related mortality, according to research presented today at the International Liver Congress.

VanWagner 

Lisa B. VanWagner

“We have demonstrated that [nonalcoholic steatohepatitis] NASH patients have an increased risk of cardiovascular disease-related mortality within 30 days following liver transplant compared to other indications for transplant, even after controlling for pre-existing cardiac risk factors,” Lisa B. VanWagner, MD, MS, clinical fellow in the division of gastroenterology and hepatology, Northwestern University Feinberg School of Medicine, told Healio.com. More »


Featured News